170 related articles for article (PubMed ID: 30180723)
1. Management of radiation-induced nausea and vomiting with palonosetron in patients with pre-existing emesis: a pilot study.
Ganesh V; Chan S; Zhang L; Drost L; DeAngelis C; Wan BA; Pasetka M; Tsao M; Barnes E; Pulenzas N; Chung H; Zaki P; Yee C; Chow E
Ann Palliat Med; 2018 Oct; 7(4):385-392. PubMed ID: 30180723
[TBL] [Abstract][Full Text] [Related]
2. A pilot study with palonosetron in the prophylaxis of radiation-induced nausea and vomiting.
Ganesh V; Drost L; DeAngelis C; Wan BA; Pasetka M; Chan S; Zhang L; Tsao M; Barnes E; Pulenzas N; Chung H; Zaki P; Yee C; Chow E
Ann Palliat Med; 2018 Apr; 7(2):211-220. PubMed ID: 29764183
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
Chow R; Tsao M; Chiu L; Popovic M; Milakovic M; Lam H; DeAngelis C
Ann Palliat Med; 2018 Apr; 7(2):221-233. PubMed ID: 29764184
[TBL] [Abstract][Full Text] [Related]
4. Evolution of antiemetic studies for radiation-induced nausea and vomiting within an outpatient palliative radiotherapy clinic.
McKenzie E; Chan D; Parsafar S; Razvi Y; McFarlane T; Rico V; Pasetka M; DeAngelis C; Chow E
Support Care Cancer; 2019 Sep; 27(9):3245-3252. PubMed ID: 31119459
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the 3-day recall period for the Functional Life Index-Emesis (FLIE).
Wan BA; Drost L; Ganesh V; Zhang L; Yee C; Tsao M; Barnes E; Pasetka M; DeAngelis C; Chow E
Ann Palliat Med; 2018 Oct; 7(4):393-403. PubMed ID: 30180722
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.
Oyama K; Fushida S; Kaji M; Takeda T; Yabushita K; Nezuka H; Kinami S; Kadoya N; Takai Y; Tsukioka Y; Ohyama S; Tsuji K; Tsukada T; Kinoshita J; Fujimura T; Ohta T
Int J Clin Oncol; 2016 Jun; 21(3):483-90. PubMed ID: 26507140
[TBL] [Abstract][Full Text] [Related]
7. Should palonosetron be a preferred 5-HT
Chow R; Warr DG; Navari RM; Tsao M; Popovic M; Chiu L; Milakovic M; Lam H; DeAngelis C
Support Care Cancer; 2018 Aug; 26(8):2519-2549. PubMed ID: 29796708
[TBL] [Abstract][Full Text] [Related]
8. Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study.
Deauna-Limayo D; Aljitawi OS; Ganguly S; Abhyankar S; Wick JA; McGuirk JP
J Oncol Pharm Pract; 2014 Aug; 20(4):263-9. PubMed ID: 24005093
[TBL] [Abstract][Full Text] [Related]
9. Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study.
Seol YM; Kim HJ; Choi YJ; Lee EM; Kim YS; Oh SY; Koh SJ; Baek JH; Lee WS; Joo YD; Lee HG; Yun EY; Chung JS
Support Care Cancer; 2016 Feb; 24(2):945-952. PubMed ID: 26265119
[TBL] [Abstract][Full Text] [Related]
10. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron.
Eisenberg P; Figueroa-Vadillo J; Zamora R; Charu V; Hajdenberg J; Cartmell A; Macciocchi A; Grunberg S;
Cancer; 2003 Dec; 98(11):2473-82. PubMed ID: 14635083
[TBL] [Abstract][Full Text] [Related]
11. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
Saito M; Aogi K; Sekine I; Yoshizawa H; Yanagita Y; Sakai H; Inoue K; Kitagawa C; Ogura T; Mitsuhashi S
Lancet Oncol; 2009 Feb; 10(2):115-24. PubMed ID: 19135415
[TBL] [Abstract][Full Text] [Related]
12. Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting-a pilot study.
Wong E; Pulenzas N; Bedard G; DeAngelis C; Zhang L; Tsao M; Danjoux C; Thavarajah N; Lechner B; McDonald R; Cheon PM; Chow E
Curr Oncol; 2015 Jun; 22(3):199-210. PubMed ID: 26089719
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H
Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447
[TBL] [Abstract][Full Text] [Related]
14. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
Jeremić B
Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
[TBL] [Abstract][Full Text] [Related]
15. Palonosetron (Aloxi) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy.
Musso M; Scalone R; Bonanno V; Crescimanno A; Polizzi V; Porretto F; Bianchini C; Perrone T
Support Care Cancer; 2009 Feb; 17(2):205-9. PubMed ID: 18839220
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of radiation-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
Li WS; van der Velden JM; Ganesh V; Vuong S; Raman S; Popovic M; Lam H; Wong KH; Ngan RK; Burbach JPM; DeAngelis C; Xxxx RM; Chow E
Ann Palliat Med; 2017 Apr; 6(2):104-117. PubMed ID: 28249542
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of radiotherapy-induced nausea and vomiting in the palliative treatment of bone metastases.
Dennis K; Nguyen J; Presutti R; DeAngelis C; Tsao M; Danjoux C; Barnes E; Sahgal A; Holden L; Jon F; Wong S; Chow E
Support Care Cancer; 2012 Aug; 20(8):1673-8. PubMed ID: 21901298
[TBL] [Abstract][Full Text] [Related]
18. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
[TBL] [Abstract][Full Text] [Related]
19. [Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study].
Nukariya N; Kobayashi K; Ishihara Y; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
Gan To Kagaku Ryoho; 1996 May; 23(6):757-71. PubMed ID: 8645027
[TBL] [Abstract][Full Text] [Related]
20. [Perceptual gap between oncologists/oncology nurses and patients in the management and impact of chemotherapy/radiotherapy-induced nausea and vomiting: French results of the GAP survey].
Morin S; Leurs I; Bousquet MN; Scotté F
Bull Cancer; 2016 May; 103(5):469-77. PubMed ID: 27015797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
